{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:40:10Z","timestamp":1759776010896},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijrobp.2016.05.023","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T15:14:35Z","timestamp":1465658075000},"page":"379-386","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dosimetric and Clinical Outcomes With Intensity Modulated Radiation Therapy After Chemotherapy for Patients With Early-Stage Diffuse Large B-cell Lymphoma of Waldeyer Ring"],"prefix":"10.1016","volume":"96","author":[{"given":"Yong-Gang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Nan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning-Ning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Rong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.05.023_bib1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1080\/10428190802493686","article-title":"Non-Hodgkin lymphoma of the Waldeyer's ring: Clinicopathologic and therapeutic issues","volume":"49","author":"Laskar","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00277-010-0970-9","article-title":"Primary tonsillar lymphomas according to the new World Health Organization classification: To report 87 cases and literature review and analysis","volume":"89","author":"Mohammadianpanah","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3904\/kjim.2014.29.3.352","article-title":"Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: Nationwide Korean study","volume":"29","author":"Lee","year":"2014","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib4","first-page":"105","article-title":"Prognostic significance of International Prognostic Index in non-Hodgkin's lymphoma of Waldeyer's ring","volume":"11","author":"Li","year":"2002","journal-title":"Chin J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hed.1077","article-title":"Localized non-Hodgkin's lymphoma of Waldeyer's ring: Clinical features, management, and prognosis of 130 adult patients","volume":"23","author":"Ezzat","year":"2001","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib6","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","article-title":"Clinical features and treatment outcome of nasal-type NK\/T-cell lymphoma of Waldeyer ring","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/COC.0b013e318261084b","article-title":"Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK\/T-cell lymphoma and diffuse large B-cell lymphoma","volume":"37","author":"Wu","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-6-77","article-title":"Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution","volume":"6","author":"Yang","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib9","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2005.07.155","article-title":"Diffuse large B-cell lymphoma: Clinical and biological characterization and outcome according to the nodal or extranodal primary origin","volume":"23","author":"L\u00f3pez-Guillermo","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib10","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/annonc\/mds150","article-title":"Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: A GELA study","volume":"23","author":"de Leval","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib11","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1002\/cncr.24557","article-title":"Diffuse large B-cell lymphoma: Clinical characterization and prognosis of Waldeyer ring versus lymph node presentation","volume":"115","author":"Qi","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib12","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1200\/JCO.2015.61.7654","article-title":"Treatment selection and survival outcomes in early-stage diffuse large B-cell lymphoma: Do\u00a0we still need consolidative radiotherapy?","volume":"33","author":"Vargo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2013.51.4505","article-title":"Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma","volume":"32","author":"Held","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib14","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2009.27.3441","article-title":"Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy","volume":"28","author":"Phan","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/10428194.2012.710907","article-title":"Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy","volume":"54","author":"Mian","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/cncr.22841","article-title":"Primary diffuse large B-cell lymphoma of the tonsil: Is a higher radiotherapy dose required?","volume":"110","author":"Laskar","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib17","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1080\/10428190600733531","article-title":"Primary non-Hodgkin's lymphoma of the nasopharynx: Prognostic factors and outcome of 113 Indian patients","volume":"47","author":"Laskar","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib19","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.2004.06.088","article-title":"Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484","volume":"22","author":"Horning","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.2006.07.0722","article-title":"CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de l'Adulte","volume":"25","author":"Bonnet","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0360-3016(02)02724-4","article-title":"Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience","volume":"53","author":"Lee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijrobp.2003.08.004","article-title":"Intensity-modulated radiation therapy for oropharyngeal carcinoma: Impact of tumor volume","volume":"59","author":"Chao","year":"2004","journal-title":"Int J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.ijrobp.2004.05.022","article-title":"Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience","volume":"60","author":"Kam","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijrobp.2005.03.006","article-title":"Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience","volume":"64","author":"de Arruda","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib25","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1748-717X-8-20","article-title":"Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer: A retrospective single center analysis","volume":"8","author":"Saleh-Ebrahimi","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib28","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jjco\/hys169","article-title":"IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: Plan evaluation and treatment outcome","volume":"42","author":"Kim","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study\u00a0comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2011.02.039","article-title":"Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early stage nasal NK\/T-cell lymphoma","volume":"82","author":"Wang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ijrobp.2013.08.040","article-title":"High-dose and extended-field intensity modulated radiotherapy for early stage NK\/T-cell lymphoma of Waldeyer's ring: Dosimetric analysis and clinical outcome","volume":"87","author":"Bi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl\u00a03","key":"10.1016\/j.ijrobp.2016.05.023_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3171\/jns.2000.93.supplement_3.0219","article-title":"A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note","volume":"93","author":"Paddick","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib33","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ijrobp.2003.09.086","article-title":"Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer","volume":"58","author":"Murshed","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ijrobp.2008.12.053","article-title":"A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation","volume":"75","author":"Rodrigures","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2011.11.008","article-title":"Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early stage Hodgkin's lymphoma with mediastinal involvement","volume":"84","author":"Lu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.ijrobp.2012.10.037","article-title":"Dosimetric evaluation and clinical outcomes of intensity-modulated radiation therapy following doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma","volume":"85","author":"Xu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ijrobp.2016.01.027","article-title":"Intensity modulated radiotherapy for early-stage primary gastric diffuse large B-cell lymphoma: Dosimetric analysis, clinical outcome, and quality of life","volume":"95","author":"Liu","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0360-3016(99)00247-3","article-title":"Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer","volume":"45","author":"Eisbruch","year":"1999","journal-title":"Int J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2004.12.076","article-title":"Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy","volume":"62","author":"Blanco","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib42","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: Field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","article-title":"Modern radiation therapy for nodal non-Hodgkin lymphoma: Target definition and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"89","author":"Illidge","year":"2014","journal-title":"Int J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib46","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/cncr.26687","article-title":"Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: Involved-field versus involved-node radiotherapy","volume":"118","author":"Campbell","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.radonc.2013.07.013","article-title":"Reduction of\u00a0the treated volume to involved node radiation therapy as part of\u00a0combined modality treatment for early stage aggressive non-Hodgkin's lymphoma","volume":"109","author":"Verhappen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.05.023_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijrobp.2014.12.042","article-title":"Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma","volume":"92","author":"Kwon","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616302796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616302796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T16:43:53Z","timestamp":1568047433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616302796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0360301616302796"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.05.023","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric and Clinical Outcomes With Intensity Modulated Radiation Therapy After Chemotherapy for Patients With Early-Stage Diffuse Large B-cell Lymphoma of Waldeyer Ring","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}